Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00516269 | Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | terminated | Phase 3 | 42 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT00290654 | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ | terminated | Phase 2 | 45 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00376805 | Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer | terminated | Phase 2 | 6 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00379197 | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer | terminated | Phase 2 | 13 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00602446 | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant | terminated | Phase 2 | 4 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT01012362 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | terminated | Phase 1 | 31 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT01372618 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor | terminated | Phase 1 / Phase 2 | 9 | NYU Langone HealthOTHER | 1 | Dec 27, 2017 | clinicaltrials |
| NCT01425294 | Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment | terminated | — | 231 | AstraZenecaINDUSTRY | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00005993 | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer | terminated | Phase 1 | — | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT01649258 | Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy | terminated | Phase 1 | 29 | University of Southern CaliforniaOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00622401 | Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 | terminated | Phase 1 / Phase 2 | 8 | Beth Israel Deaconess Medical CenterOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT01176838 | A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients | terminated | — | 20 | Wake Forest UniversityOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT01050075 | Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel | terminated | N/A | 7 | City of Hope Medical CenterOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02250118 | Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer(BEVAP) | terminated | Phase 1 | 1 | Institut CurieOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00581529 | Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy | terminated | Phase 2 | 34 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT02239315 | Study of Tumor RNA Disruption Assay™ (RDA)(RnaDx) | terminated | N/A | 1 | University of TorontoOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT01187381 | An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(HERODOT) | terminated | — | 250 | Hoffmann-La RocheINDUSTRY | 1 | Oct 20, 2017 | clinicaltrials |
| NCT01512199 | Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) | terminated | Phase 1 / Phase 2 | 29 | Daiichi SankyoINDUSTRY | 2 | Oct 18, 2017 | clinicaltrials |
| NCT02017496 | Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment(NeoBCT) | terminated | — | 18 | Oslo University HospitalOTHER | 1 | Oct 17, 2017 | clinicaltrials |
| NCT00813878 | Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | terminated | — | 126 | City of Hope Medical CenterOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT01217489 | Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease(Signascan) | terminated | — | 300 | Oxford University Hospitals NHS TrustOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT00725946 | Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT | terminated | Early Phase 1 | 7 | Stanford UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT02863146 | Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer | terminated | — | 23 | Centre Oscar LambretOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT01939418 | Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 23 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 3, 2017 | clinicaltrials |
| NCT00003454 | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 19 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00684216 | Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer | terminated | Phase 2 / Phase 3 | 10 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT00754767 | L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer | terminated | Phase 4 | 2 | HealthPartners InstituteOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT02712437 | Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer | terminated | N/A | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 8, 2017 | clinicaltrials |
| NCT00832338 | Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | terminated | Phase 2 | 23 | Emory UniversityOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01319539 | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | terminated | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01351844 | The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer(CEASE) | terminated | N/A | 12 | George Washington UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT02360059 | Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT02074878 | CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer(CRIZENT) | terminated | Phase 1 | 3 | Mothaffar RimawiOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT01114256 | FNA Tumor Sampling for CD137 Modulation: A Pilot Study | terminated | — | 83 | Stanford UniversityOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT00206492 | Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients | terminated | Phase 2 | 3 | Baylor Breast Care CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00899197 | Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer | terminated | — | 2 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01436604 | Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging(MRTOX) | terminated | Phase 2 | 19 | Centre Francois BaclesseOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02040493 | Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer | terminated | N/A | 75 | Xoft, Inc.INDUSTRY | 1 | Jul 25, 2017 | clinicaltrials |
| NCT01847599 | Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib(ProMETheX) | terminated | N/A | 65 | Centre Jean PerrinOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT00041470 | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial | terminated | Phase 1 / Phase 2 | 38 | University of WashingtonOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00194792 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | terminated | Phase 2 | 28 | University of WashingtonOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01754519 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | terminated | Phase 2 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01222416 | PET/CT Evaluation of Treatment Response in Breast Cancer | terminated | N/A | 50 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01918306 | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT00375752 | Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer(FEMZONE) | terminated | Phase 4 | 168 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 26, 2017 | clinicaltrials |
| NCT01868503 | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT00638963 | Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)(STOP) | terminated | Phase 2 | 6 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 14, 2017 | clinicaltrials |
| NCT00604968 | Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059) | terminated | Phase 4 | 25 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 7, 2017 | clinicaltrials |
| NCT00932035 | Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 39 | City of Hope Medical CenterOTHER | 1 | Jun 7, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jan 3, 2018source: clinicaltrials